$85.24
1.18% today
NYSE, May 15, 06:45 pm CET
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Stock price

$84.25
+0.03 0.04% 1M
-1.75 2.03% 6M
+4.37 5.47% YTD
-0.05 0.06% 1Y
-19.56 18.84% 3Y
-9.57 10.20% 5Y
+7.99 10.48% 10Y
NYSE, Closing price Wed, May 14 2025
-0.86 1.01%
ISIN
IE00BTN1Y115
Symbol
MDT
Sector

Key metrics

Market capitalization $108.05b
Enterprise Value $126.97b
P/E (TTM) P/E ratio 25.61
EV/FCF (TTM) EV/FCF 23.22
EV/Sales (TTM) EV/Sales 3.82
P/S ratio (TTM) P/S ratio 3.25
P/B ratio (TTM) P/B ratio 2.19
Dividend yield 3.32%
Last dividend (FY25) $2.80
Revenue growth (TTM) Revenue growth 2.72%
Revenue (TTM) Revenue $33.20b
EBIT (operating result TTM) EBIT $6.19b
Free Cash Flow (TTM) Free Cash Flow $5.47b
Cash position $7.92b
EPS (TTM) EPS $3.29
P/E forward 20.68
P/S forward 3.23
EV/Sales forward 3.79
Short interest 0.96%
Show more

Is Medtronic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Medtronic Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Medtronic forecast:

16x Buy
48%
14x Hold
42%
3x Sell
9%

Analyst Opinions

33 Analysts have issued a Medtronic forecast:

Buy
48%
Hold
42%
Sell
9%

Financial data from Medtronic

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jan '25
+/-
%
33,199 33,199
3% 3%
100%
- Direct Costs 13,172 13,172
3% 3%
40%
20,027 20,027
3% 3%
60%
- Selling and Administrative Expenses 8,438 8,438
4% 4%
25%
- Research and Development Expense 2,723 2,723
1% 1%
8%
8,866 8,866
2% 2%
27%
- Depreciation and Amortization 2,675 2,675
0% 0%
8%
EBIT (Operating Income) EBIT 6,191 6,191
4% 4%
19%
Net Profit 4,259 4,259
1% 1%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Medtronic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medtronic Stock News

Positive
Seeking Alpha
one day ago
Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year, but now faces a pivotal earnings event on the 21st of May. Cardiovascular portfolio strength, especially from Pulse Field Ablation products, and a convalescing medical surgical outlook, underpin our optimism, while gross margin and SG&A progress is likely to be seen. While the expected dividend hike may...
Neutral
PRNewsWire
8 days ago
GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m.
Neutral
PRNewsWire
8 days ago
Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-fig...
More Medtronic News

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Head office United States
CEO Geoffrey Martha
Employees 95,000
Founded 2014
Website www.medtronic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today